Bhumi Pharmaceuticals — Mebendazole Exporter Profile
Indian Pharmaceutical Exporter · #15 for Mebendazole · $158.3K export value · DGFT Verified
Bhumi Pharmaceuticals is the #15 Indian exporter of Mebendazole with $158.3K in export value and 24 verified shipments. Bhumi Pharmaceuticals holds a 1.2% market share in Mebendazole exports across 3 countries. The company exports 2 pharmaceutical products worth $1.5M across 2 therapeutic categories.
Bhumi Pharmaceuticals — Mebendazole Export Profile: Buyers & Destinations
Where Does Bhumi Pharmaceuticals Export Mebendazole?
| Country | Value | Shipments | Share |
|---|---|---|---|
| LIBERIA | $145.3K | 20 | 91.8% |
| ANGOLA | $9.5K | 2 | 6.0% |
| SOMALIA | $3.4K | 2 | 2.2% |
Bhumi Pharmaceuticals exports Mebendazole to 3 countries. The largest destination is LIBERIA accounting for 91.8% of Bhumi Pharmaceuticals's Mebendazole shipments, followed by ANGOLA (6.0%) and SOMALIA (2.2%). These destinations reflect Bhumi Pharmaceuticals's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Mebendazole from Bhumi Pharmaceuticals?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| SBR GROUP OF COMPANIES | LIBERIA | $131.5K | 17 |
| SBR GROUP OF COMPANIES, | LIBERIA | $13.8K | 3 |
| BUNTY FARMA, | ANGOLA | $4.9K | 1 |
| BUNTY FARMA | ANGOLA | $4.6K | 1 |
| MOUMIN GROUP | SOMALIA | $3.4K | 2 |
Bhumi Pharmaceuticals supplies Mebendazole to 5 buyers globally. The largest buyer is SBR GROUP OF COMPANIES (LIBERIA), followed by SBR GROUP OF COMPANIES, (LIBERIA) and BUNTY FARMA, (ANGOLA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Mebendazole Export Value and How Much Does Bhumi Pharmaceuticals Contribute?
India exported $7.1M worth of Mebendazole through 2,932 shipments from 259 suppliers to 108 countries, serving 756 buyers globally. Bhumi Pharmaceuticals contributes $158.3K to this total, accounting for 1.2% of India's Mebendazole exports. Bhumi Pharmaceuticals ships Mebendazole to 3 countries through 5 buyers.
What Is the Average Shipment Value for Bhumi Pharmaceuticals's Mebendazole Exports?
Bhumi Pharmaceuticals's average Mebendazole shipment value is $6.6K per consignment, based on 24 shipments totaling $158.3K. The largest destination is LIBERIA (91.8% of Bhumi Pharmaceuticals's Mebendazole exports).
How Does Bhumi Pharmaceuticals Compare to Other Indian Mebendazole Exporters?
Bhumi Pharmaceuticals ranks #15 among 259 Indian Mebendazole exporters with a 1.2% market share. The top 3 exporters are CADILA PHARMACEUTICALS LIMITED ($2.7M), LINCOLN PHARMACEUTICALS LTD ($1.1M), J B CHEMICALS AND PHARMACEUTICALS LIMITED ($539.7K). Bhumi Pharmaceuticals processed 24 shipments to 3 destination countries.
What Mebendazole Formulations Does Bhumi Pharmaceuticals Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| VOMEX 100 10x1x6Mebendazole Tablets U | $25.6K | 2 |
| VOMEX 100 (10x1x6) (Mebendazole Tablets | $25.5K | 2 |
| VOMEX 100 TABLET(10X1X6) (MEBENDAZOLE TABLETS UPS 100MG) | $21.5K | 1 |
| VOMEX 100 10X1X6Mebendazole Tablets USP 100mg | $13.0K | 1 |
| VOMEX 100 TABLET (10X1X6)(MEBENDAZOLE TABLETS USP 100MG) | $11.4K | 1 |
| BHUMI S VOMEX 100 (10X1X6)(Mebendazole tablets USP 100 mg) | $11.4K | 1 |
| VOMEX 100 (10X1X6)(MEBENDAZOLE TABLETS USP 100MG) | $10.6K | 1 |
| BHUMI S VOMEX 100 10X1X6 Mebendazole Tablets USP 100 mg | $8.4K | 1 |
| BHUMI S VOMEX 100 (10X1X6)(Mebendazole Tablets USP 100 mg) | $7.0K | 1 |
| VOMEX 100 (10X1X6)(Mebendazole Tablets USP 100 mg) | $6.1K | 1 |
Bhumi Pharmaceuticals exports 17 distinct Mebendazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VOMEX 100 10x1x6Mebendazole Tablets U with 2 shipments worth $25.6K.
How Does Bhumi Pharmaceuticals Compare to Nearest Mebendazole Exporters?
Exporters ranked immediately above and below #15 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | RONAK EXIM PRIVATE LTD | $188.4K | 45 | 4 | $4.2K |
| 14 | CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED | $166.1K | 9 | 3 | $18.5K |
| 15 | BHUMI PHARMACEUTICALS ★ | $158.3K | 24 | 3 | $6.6K |
| 1 | KROSYL PHARMACEUTICALS PRIVATE LIMITED | $150.0K | 3 | 1 | $50.0K |
| 13 | BAFNA PHARMACEUTICALS LIMITED | $150.0K | 3 | 2 | $50.0K |
Bhumi Pharmaceuticals ranks #15 among 259 Indian Mebendazole exporters. Average shipment value of $6.6K compared to the market average of $27.3K. The closest competitors by value are RONAK EXIM PRIVATE LTD and CIRON DRUGS AND PHARMACEUTICALS PRIVATE LIMITED.
Which Indian Ports Ship Mebendazole Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 513 | 17.5% |
| SAHAR AIR | 450 | 15.3% |
| NHAVA SHEVA SEA (INNSA1) | 300 | 10.2% |
| DELHI AIR CARGO ACC (INDEL4) | 289 | 9.9% |
| JNPT/ NHAVA SHEVA SEA | 170 | 5.8% |
| DELHI AIR | 162 | 5.5% |
| JNPT | 130 | 4.4% |
| AHEMDABAD ICD | 96 | 3.3% |
About Bhumi Pharmaceuticals
Bhumi Pharmaceuticals exports 2 products worth $1.5M. Beyond Mebendazole, top products include Ampicillin. View the complete Bhumi Pharmaceuticals profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Mebendazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Mebendazole shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Bhumi Pharmaceuticals matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 24 individual customs records matching Bhumi Pharmaceuticals exporting Mebendazole, covering 17 formulations to 3 countries via 5 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 108+ countries, 756+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Mebendazole Export Data from Bhumi Pharmaceuticals
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Bhumi Pharmaceuticals's Mebendazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Bhumi Pharmaceuticals
Full Company Profile →
2 products · $1.5M total trade · 2 categories
Mebendazole Stats
Company Overview
Top Products by Bhumi Pharmaceuticals
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Bhumi Pharmaceuticals.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Mebendazole. For current shipment-level data, contact TransData Nexus.